Mario Rivera-Izquierdo
Research Subjects
Research Interests
Mario Rivera-Izquierdo has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Inmaculada Guerrero-Fernández de Alba
Service of Preventive Medicine and Public Health, Hospital Universitario San Cecilio, 18016 Granada, Spain
1 shared publication - Inmaculada Salcedo
Preventive Medicine and Public Health Unit, Reina Sofía University Hospital, 14004 Córdoba, Spain
1 shared publication - Marina Pérez-Contreras
Service of Preventive Medicine and Public Health, Hospital Universitario de Puerto Real, 11510 Puerto Real, Spain
1 shared publication - Nicolás Francisco Fernández-Martínez
Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Escuela Andaluza de Salud Pública (EASP), Granada, Spain
1 shared publication - Rafael Ruiz-Montero
Preventive Medicine and Public Health Unit, Reina Sofía University Hospital, 14004 Córdoba, Spain
1 shared publication - Rocío Ortiz-González-Serna
Unidad de Gestión Clínica Interniveles de Prevención, Promoción y Vigilancia de la Salud, Hospital Universitario Reina Sofía, 14004 Córdoba, Spain
1 shared publication
Latest Publications
- Open Access
- 26 August 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (17) , 9018
Sex Differences and Predictors of In-Hospital Mortality among Patients with COVID-19: Results from the ANCOHVID Multicentre Study
Spain is one of the countries most affected by the COVID-19 pandemic. Although risk factors for severe disease are published, sex differences have been widely neglected. In this multicentre study, we aimed to identify predictors of in-hospital mortality in men and women hospitalised with COVID-19. An observational longitudinal study was conducted in the cohort of patients admitted to four hospitals in Andalusia, Spain, from 1 March 2020 to 15 April 2020. Sociodemographic and clinical data were collected from hospital records. The Kaplan–Meier method was used to estimate 30-day survival and multiple Cox regression models were applied. All analyses were stratified by sex. A total of 968 patients were included (54.8% men, median age 67.0 years). In-hospital mortality reached 19.1% in men and 16.0% in women. Factors independently associated with an increased hazard of death were advanced age, higher CURB-65 score and not receiving azithromycin treatment, in both sexes; active cancer and autoimmune disease, in men; cardiovascular disease and chronic lung disease, in women. Disease outcomes and predictors of death differed between sexes. In-hospital mortality was higher in men, but the long-term effects of COVID-19 merit further research. The sex-differential impact of the pandemic should be addressed in public health policies.
- 26 August 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (17) , 9018
Open AccessSex Differences and Predictors of In-Hospital Mortality among Patients with COVID-19: Results from the ANCOHVID Multicentre Study
Spain is one of the countries most affected by the COVID-19 pandemic. Although risk factors for severe disease are published, sex differences have been widely neglected. In this multicentre study, we aimed to identify predictors of in-hospital mortality in men and women hospitalised with COVID-19. An observational longitudinal study was conducted in the cohort of patients admitted to four hospitals in Andalusia, Spain, from 1 March 2020 to 15 April 2020. Sociodemographic and clinical data were collected from hospital records. The Kaplan–Meier method was used to estimate 30-day survival and multiple Cox regression models were applied. All analyses were stratified by sex. A total of 968 patients were included (54.8% men, median age 67.0 years). In-hospital mortality reached 19.1% in men and 16.0% in women. Factors independently associated with an increased hazard of death were advanced age, higher CURB-65 score and not receiving azithromycin treatment, in both sexes; active cancer and autoimmune disease, in men; cardiovascular disease and chronic lung disease, in women. Disease outcomes and predictors of death differed between sexes. In-hospital mortality was higher in men, but the long-term effects of COVID-19 merit further research. The sex-differential impact of the pandemic should be addressed in public health policies.